KimForest’s precision medicine products can be divided into two categories. The first category provides genetic testing, drug report and monitoring tools for cancer patients. NGS is used to detect patients’ mutations, and find relevant FDA approved drugs, off-label use drugs, and global clinical trials for these mutations. As for relapse monitoring, cell free DNA (cfDNA) is extracted from whole blood, and we identify circulating tumor DNA in cfDNA as an indicator to find cancer cells. For hereditary breast and ovarian cancers, KimForest provides BRCA1 and BRCA2 genet test.
The second category, called GoL Life, provides a non-invasive genome-wide health assessment for healthy persons. Customers’ DNA is collected from cells via mouthwash, and we decipher these DNA, detect which genes have changes, and then report the risks of different traits, such as obesity, alcohol flush reaction, and cancer. DNA almost does not change in whole life, so customers only need to have one test in whole life to understand their secret in DNA. Moreover, GoL Life is designed for Asians: we examine genes that change constantly in Asians.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 30f., No.97, Sec. 1, Xintai 5th Rd., Xizhi Dist., U-Town B,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- New Taipei City
Kimforest Questions
Kimforest's website is https://www.104.com.tw/company/ckatcjs
Kimforest's LinkedIn profile is https://www.linkedin.com/company/kimforest
Kimforest has
12 employees.
View email and phone details for 12
employees at Kimforest.
Kimforest's industry is
Biotechnology Research
Kimforest's categories are Biotechnology Research
Kimforest's founding year is 2004
